
浏览全部资源
扫码关注微信
1.重庆医科大学附属第三医院泌尿外科,重庆 401120
2.重庆大学附属涪陵医院肿瘤血液科,重庆 408000
3.陆军军医大学第一附属医院肝胆外科,重庆 400038
李泽宇,Email:522602332@qq.com,研究方向:泌尿系肿瘤。
支 轶,Email:urolzhi@aliyun.com
收稿:2024-03-09,
修回:2024-05-13,
录用:2024-05-21,
纸质出版:2024-06-28
移动端阅览
李泽宇,柳豪,黄垣堤,等.脂代谢相关基因ABHD5抑制肾癌细胞体外迁移及侵袭[J].重庆医科大学学报,2024,49(6):701-706.
Li Zeyu,Liu Hao,Huang Yuandi,et al.Lipid metabolism-related gene ABHD5 inhibits renal cancer cell migration and invasion in vitro[J].Journal of Chongqing Medical University,2024,49(6):701-706.
李泽宇,柳豪,黄垣堤,等.脂代谢相关基因ABHD5抑制肾癌细胞体外迁移及侵袭[J].重庆医科大学学报,2024,49(6):701-706. DOI: 10.13406/j.cnki.cyxb.003510.
Li Zeyu,Liu Hao,Huang Yuandi,et al.Lipid metabolism-related gene ABHD5 inhibits renal cancer cell migration and invasion in vitro[J].Journal of Chongqing Medical University,2024,49(6):701-706. DOI: 10.13406/j.cnki.cyxb.003510.
目的
2
探讨透明细胞肾细胞癌(clear cell renal cell cancinoma,ccRcc)细胞体外迁移及侵袭过程中与α/β自水解酶结构域5(α/β-hydrolase domain-containing 5,ABHD5)的关系。
方法
2
采用TCGA数据库分析人ccRcc组织及正常肾组织中ABHD5的表达情况。采用ABHD5过表达慢病毒转染人肾透明细胞癌细胞株786-O及Caki-1后,运用real-time PCR及Western blot技术检测ABHD5表达改变情况。采用Transwell实验、划痕实验检测此基因对细胞体外迁移及侵袭能力的影响。
结果
2
TCGA数据库显示ccRcc组织中ABHD5表达较正常肾脏组织显著下降(
P
=0.000),且其下降程度在复发转移肿瘤中进一步增加(
P
=0.007),与患者生存呈显著负相关(
P
<
0.001)。Transwell实验、划痕实验显示过表达ABHD5显著抑制肾癌细胞体外迁移及侵袭能力(
P
<
0.05)。过表达ABHD5通过影响Sting信号进而影响肾癌细胞体外迁移及侵袭。
结论
2
脂代谢相关基因ABHD5抑制ccRcc癌细胞体外迁移及侵袭能力。
Objective
2
To investigated the relationship between clear cell renal cell carcinoma(ccRcc) cells and α/β-hydrolase domain-containing 5(ABHD5) during migration and invasion
in vitro
.
Methods
2
The TCGA database was used to analyze the expression of ABHD5 in human ccRcc tissues and normal kidney tissues. After transfection of human ccRcc cell lines 786-O and Caki-1 with ABHD5-overexpressing lentivirus, the changes in ABHD5 expression were detected using real-time PCR and Western blot. Transwell assay and scratch assay were used to examine the effects of ABHD5 on cell migration and invasion
in vitro
.
Results
2
TCGA database showed that the expression of ABHD5 in ccRcc tissues was significantl
y decreased compared with normal renal tissues(
P
=0.000), and the decrease was greater in recurrent metastatic tumors(
P
=0.007),which was significantly negatively correlated with the survival of the patients(
P
<
0.001). Transwell assay and scratch assay showed that ABHD5 overexpression significantly inhibited the migration and invasion of ccRcc cells
in vitro
(
P
<
0.05). Overexpression of ABHD5 inhibited renal cancer cell migration and invasion in vitro by influencing the Sting signaling pathway.
Conclusion
2
Lipid metabolism-related gene ABHD5 inhibited the migration and invasion of ccRcc cells
in vitro
.
Heravi G , Yazdanpanah O , Podgorski I , et al . Lipid metabolism reprogramming in renal cell carcinoma [J ] . Cancer Metastasis Rev , 2022 , 41 ( 1 ): 17 - 31 .
Jin HR , Wang J , Wang ZJ , et al . Lipid metabolic reprogramming in tumor microenvironment:from mechanisms to therapeutics [J ] . J Hematol Oncol , 2023 , 16 ( 1 ): 103 .
Xia LZ , Oyang L , Lin JG , et al . The cancer metabolic reprogramming and immune response [J ] . Mol Cancer , 2021 , 20 ( 1 ): 28 .
Faubert B , Solmonson A , DeBerardinis RJ . Metabolic reprogramming and cancer progression [J ] . Science , 2020 , 368 ( 6487 ): eaaw5473 .
Ou JJ , Miao HM , Ma YY , et al . Loss of Abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition [J ] . Cell Rep , 2018 , 24 ( 10 ): 2795 - 2797 .
Peng Y , Miao HM , Wu S , et al . ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2 [J ] . Autophagy , 2016 , 12 ( 11 ): 2167 - 2182 .
Gu Y , Chen YR , Wei L , et al . ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation [J ] . Nat Commun , 2021 , 12 ( 1 ): 6711 .
Snaebjornsson MT , Janaki-Raman S , Schulze A . Greasing the wheels of the cancer machine:the role of lipid metabolism in cancer [J ] . Cell Metab , 2020 , 31 ( 1 ): 62 - 76 .
Beloribi-Djefaflia S , Vasseur S , Guillaumond F . Lipid metabolic reprogramming in cancer cells [J ] . Oncogenesis , 2016 , 5 ( 1 ): e189 .
Reuter VE , Tickoo SK . Differential diagnosis of renal tumours with clear cell histology [J ] . Pathology , 2010 , 42 ( 4 ): 374 - 383 .
Qi XC , Li QL , Che XY , et al . The uniqueness of clear cell renal cell carcinoma:summary of the process and abnormality of glucose metabolism and lipid metabolism in ccRCC [J ] . Front Oncol , 2021 , 11 : 727778 .
Chen GH , Zhou GL , Aras S , et al . Loss of ABHD5 promotes the aggressiveness of prostate cancer cells [J ] . Sci Rep , 2017 , 7 : 13021 .
Wang X , Liu MY , Zhang JF , et al . CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder [J ] . Cell Metab , 2022 , 34 ( 8 ): 1088 - 1103 .
Zhu ZC , Zhou X , Du HW , et al . STING suppresses mitochondrial VDAC2 to govern RCC growth independent of innate immunity [J ] . Adv Sci , 2023 , 10 ( 3 ): e2203718 .
Hu J , Sánchez-Rivera FJ , Wang ZH , et al . STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma [J ] . Nature , 2023 , 616 ( 7958 ): 806 - 813 .
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621